CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C02804 | BRD-K01284917 | BRD-K01284917 | -- | -- | -- | Details |
| C02805 | BRD-K01285236 | BRD-K01285236 | -- | -- | -- | Details |
| C02806 | BRD-K01286616 | BRD-K01286616 | -- | -- | -- | Details |
| C02807 | BRD-K01289045 | BRD-K01289045 | -- | -- | -- | Details |
| C02808 | BRD-K01291782 | molidustat | -- | -- | -- | Details |
| C02809 | BRD-K01292756 | pimozide | DRD2; DRD3; HTR2A | Dopamine receptor antagonist | -- | Details |
| C02810 | BRD-K01296372 | BRD-K01296372 | -- | -- | -- | Details |
| C02811 | BRD-K01297681 | BRD-K01297681 | -- | -- | -- | Details |
| C02812 | BRD-K01310096 | BRD-K01310096 | -- | -- | -- | Details |
| C02813 | BRD-K01311880 | BRD-K01311880 | -- | -- | -- | Details |
| C02814 | BRD-K01312966 | BRD-K01312966 | -- | -- | -- | Details |
| C02815 | BRD-K01314849 | BRD-K01314849 | -- | -- | -- | Details |
| C02816 | BRD-K01316590 | BRD-K01316590 | -- | -- | -- | Details |
| C02817 | BRD-K01317665 | BRD-K01317665 | -- | -- | -- | Details |
| C02818 | BRD-K01326303 | BRD-K01326303 | -- | -- | -- | Details |
| C02819 | BRD-K01329157 | BRD-K01329157 | -- | -- | -- | Details |
| C02820 | BRD-K01329192 | BRD-K01329192 | -- | -- | -- | Details |
| C02821 | BRD-K01333970 | BRD-K01333970 | -- | -- | -- | Details |
| C02822 | BRD-K01334037 | BRD-K01334037 | -- | -- | -- | Details |
| C02823 | BRD-K01335229 | BRD-K01335229 | -- | -- | -- | Details |
| C02824 | BRD-K01335708 | BRD-K01335708 | -- | -- | -- | Details |
| C02825 | BRD-K01348631 | BRD-K01348631 | -- | -- | -- | Details |
| C02826 | BRD-K01351858 | BRD-K01351858 | -- | -- | -- | Details |
| C02827 | BRD-K01352631 | BRD-K01352631 | -- | -- | -- | Details |
| C02828 | BRD-K01355066 | BRD-K01355066 | -- | -- | -- | Details |
| C02829 | BRD-K01358985 | BRD-K01358985 | -- | -- | -- | Details |
| C02830 | BRD-K01359264 | BRD-K01359264 | -- | -- | -- | Details |
| C02831 | BRD-K01360791 | BRD-K01360791 | -- | -- | -- | Details |
| C02832 | BRD-K01362004 | BRD-K01362004 | -- | -- | -- | Details |
| C02833 | BRD-K01363385 | antalarmin | -- | -- | -- | Details |
| C02834 | BRD-K01367715 | BRD-K01367715 | -- | -- | -- | Details |
| C02835 | BRD-K01369591 | acronycine | -- | -- | -- | Details |
| C02836 | BRD-K01371603 | BRD-K01371603 | -- | -- | -- | Details |
| C02837 | BRD-K01373529 | BRD-K01373529 | -- | -- | -- | Details |
| C02838 | BRD-K01377768 | BRD-K01377768 | -- | -- | -- | Details |
| C02839 | BRD-K01383339 | BRD-K01383339 | -- | -- | -- | Details |
| C02840 | BRD-K01389427 | BRD-K01389427 | -- | -- | -- | Details |
| C02841 | BRD-K01397631 | BRD-K01397631 | -- | -- | -- | Details |
| C02842 | BRD-K01400178 | ST-209453 | -- | -- | -- | Details |
| C02843 | BRD-K01404579 | BRD-K01404579 | -- | -- | -- | Details |
| C02844 | BRD-K01405464 | BRD-K01405464 | -- | -- | -- | Details |
| C02845 | BRD-K01409032 | BRD-K01409032 | -- | -- | -- | Details |
| C02846 | BRD-K01409647 | BRD-K01409647 | -- | -- | -- | Details |
| C02847 | BRD-K01416914 | simazine | -- | -- | -- | Details |
| C02848 | BRD-K01417352 | BRD-K01417352 | -- | -- | -- | Details |
| C02849 | BRD-K01425313 | BRD-K01425313 | -- | -- | -- | Details |
| C02850 | BRD-K01425431 | BRD-K01425431 | -- | -- | -- | Details |
| C02851 | BRD-K01427177 | BRD-K01427177 | -- | -- | -- | Details |
| C02852 | BRD-K01435720 | BRD-K01435720 | -- | -- | -- | Details |
| C02853 | BRD-K01436366 | XMD-1150 | LRRK2 | Leucine rich repeat kinase inhibitor | -- | Details |
| C02854 | BRD-K01448700 | BRD-K01448700 | -- | -- | -- | Details |
| C02855 | BRD-K01452910 | BRD-K01452910 | -- | -- | -- | Details |
| C02856 | BRD-K01463627 | BRD-K01463627 | -- | -- | -- | Details |
| C02857 | BRD-K01463939 | BRD-K01463939 | -- | -- | -- | Details |
| C02858 | BRD-K01464244 | BRD-K01464244 | -- | -- | -- | Details |
| C02859 | BRD-K01467488 | BRD-K01467488 | -- | -- | -- | Details |
| C02860 | BRD-K01473791 | BRD-K01473791 | -- | -- | -- | Details |
| C02861 | BRD-K01477275 | BRD-K01477275 | -- | -- | -- | Details |
| C02862 | BRD-K01478290 | BRD-K01478290 | -- | -- | -- | Details |
| C02863 | BRD-K01478916 | BRD-K01478916 | -- | -- | -- | Details |
| C02864 | BRD-K01490356 | BRD-K01490356 | -- | -- | -- | Details |
| C02865 | BRD-K01493881 | apigenin | -- | -- | -- | Details |
| C02866 | BRD-K01497006 | BRD-K01497006 | -- | -- | -- | Details |
| C02867 | BRD-K01497355 | BRD-K01497355 | -- | -- | -- | Details |
| C02868 | BRD-K01507359 | rifampicin | NR1I2 | RNA polymerase inhibitor | -- | Details |
| C02869 | BRD-K01512588 | BRD-K01512588 | -- | -- | -- | Details |
| C02870 | BRD-K01516250 | adipamide | -- | -- | -- | Details |
| C02871 | BRD-K01520595 | BRD-K01520595 | -- | -- | -- | Details |
| C02872 | BRD-K01520647 | BRD-K01520647 | -- | -- | -- | Details |
| C02873 | BRD-K01523435 | BRD-K01523435 | -- | -- | -- | Details |
| C02874 | BRD-K01528688 | BRD-K01528688 | -- | -- | -- | Details |
| C02875 | BRD-K01534436 | BRD-K01534436 | -- | -- | -- | Details |
| C02876 | BRD-K01536322 | BRD-K01536322 | -- | -- | -- | Details |
| C02877 | BRD-K01543453 | BRD-K01543453 | -- | -- | -- | Details |
| C02878 | BRD-K01547088 | BRD-K01547088 | -- | -- | -- | Details |
| C02879 | BRD-K01547285 | BRD-K01547285 | -- | -- | -- | Details |
| C02880 | BRD-K01549188 | bms | -- | -- | -- | Details |
| C02881 | BRD-K01554997 | BRD-K01554997 | -- | -- | -- | Details |
| C02882 | BRD-K01555864 | dibenzoylmethane | -- | -- | -- | Details |
| C02883 | BRD-K01556781 | BRD-K01556781 | -- | -- | -- | Details |
| C02884 | BRD-K01558205 | BRD-K01558205 | -- | -- | -- | Details |
| C02885 | BRD-K01566563 | BRD-K01566563 | -- | -- | -- | Details |
| C02886 | BRD-K01567962 | pyrazolanthrone | MAPK8; MAPK9; MAPK10; TTK | JNK inhibitor | -- | Details |
| C02887 | BRD-K01568615 | BRD-K01568615 | -- | -- | -- | Details |
| C02888 | BRD-K01570637 | BRD-K01570637 | -- | -- | -- | Details |
| C02889 | BRD-K01572707 | BRD-K01572707 | -- | -- | -- | Details |
| C02890 | BRD-K01573538 | BRD-K01573538 | -- | -- | -- | Details |
| C02891 | BRD-K01575212 | BRD-K01575212 | -- | -- | -- | Details |
| C02892 | BRD-K01576758 | BRD-K01576758 | -- | -- | -- | Details |
| C02893 | BRD-K01577807 | BRD-K01577807 | -- | -- | -- | Details |
| C02894 | BRD-K01577834 | adenosine | ADORA1; ADORA2A; ADORA2B; ADORA3 | Adenosine receptor agonist | -- | Details |
| C02895 | BRD-K01578344 | BRD-K01578344 | -- | -- | -- | Details |
| C02896 | BRD-K01591707 | BRD-K01591707 | -- | -- | -- | Details |
| C02897 | BRD-K01594626 | BRD-K01594626 | -- | -- | -- | Details |
| C02898 | BRD-K01594666 | BRD-K01594666 | -- | -- | -- | Details |
| C02899 | BRD-K01594737 | BRD-K01594737 | -- | -- | -- | Details |
| C02900 | BRD-K01594854 | BRD-K01594854 | -- | -- | -- | Details |
| C02901 | BRD-K01595245 | BRD-K01595245 | -- | -- | -- | Details |
| C02902 | BRD-K01602319 | BRD-K01602319 | -- | -- | -- | Details |
| C02903 | BRD-K01604266 | BRD-K01604266 | -- | -- | -- | Details |